期刊文献+

青年急性心肌梗死患者脂蛋白(a)水平的变化及其意义 被引量:248

The change of lipoprotein(a) concentration and the relationship to the coagulative variables in young patients with acute myocardial infarction
原文传递
导出
摘要 目的:探讨脂蛋白(a)[Lp(a)]水平在青年急性心肌梗死(AMI)患者中的变化及其与凝血指标的关系。方法:对32例青年AMI患者、30例青年冠心病(CHD)患者及36例正常对照者进行冠状动脉(冠脉)造影术,并检测其血中Lp(a)、D-二聚体(D-D)、纤溶酶原活性(Pig)、抗凝血酶原(AT-Ⅲ)及组织纤溶酶原激活物(t-PA)的水平。结果:①AMI组和CHD组Lp(a)明显高于正常对照组[(230±60)和(190±20):(110±20)mg/L,P<0.05],但前两组之间差异无显著性意义(P>0.05);②高Lp(a)血症患者AMI的发生率明显高于血清Lp(a)正常的患者(47%:15%,P<0.01);③AMI组D-D明显高于CHD组和正常对照组(12±5):(4±3)mg/L和(2±1)mg/L,P<0.01);④冠脉多支病变者Lp(a)的水平明显高于单支病变者(P<0.01)。结论:青年AMI患者中存在Lp(a)水平增高,并与D-D水平及冠脉病变支数呈正相关。 Objective:To observe the change of lipoprotein(a) concentrations and its relationship to the coagu-lative variables in young patients with acute myocardial infarction. Methods: Ninty eight young subjects were divided into 3 groups: (1)acute myocardial infarction(AMI) group( n = 32);(2)CHD group(n =30); (3)normal control group(n =36). Their serum lipoprotein (a), d-dimer, Pig, t-PA and AT-Ⅲ were detected by ELISA. Results: (1) Compared to control group, there were significant increase of lipoprotein(a) in AMI and CHD group (230±60)mg/L and (190±20)mg/L v. s. (110±20)mg/L, P <0. 05), but there was not significant change in latter two groups. (2) D-dimer concentrations in AMI group were more significantly increased than those in CHD and control group(12±5) mg/L v. s. (4 ± 3) mg/L and (2±1) mg/L, P <0. 01); (3) Lp(a) concentrations in multi-vessel disease's patients were more significantly increased than those in single vessel disease's patients ( P < 0. 01). Conclusion: The Lp(a) concentrations in the young patients with AMI are incresed, and are positively related to d-dimer concentrations and to the number of damaged corondry arteny.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2002年第10期500-502,共3页 Journal of Clinical Cardiology
关键词 急性心肌梗死 脂蛋白(a) 凝血指标 老年人 临床意义 Myocardial infarction Lipoprotein(a) Coagulative variables
  • 相关文献

参考文献7

  • 1Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
  • 2Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
  • 3Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
  • 4Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.
  • 5Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280.
  • 6Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150.
  • 7Greory Y H, Gordon D L. Fibrin D-dimer: A useful marker of thrombogenesis? Clini Sci,1995(89):205-214.

同被引文献916

引证文献248

二级引证文献1494

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部